October 10, 2005
Pharmacosmos has launched a new dextran website, which presents our dextran products and dextran GPC Standards.
The dextran website contains comprehensible information about dextran properties, dextran structure, physico-chemical and chemical properties of dextran, dextran applications and analysis technics.
Please visit: www.dextran.net
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.